Moderna, Inc.: Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...
Moderna receives MHRA marketing authorization for RSV vaccine
Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for ...
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc.
Investor's Business Daily on MSN3h
Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?
Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...
New vaccine approved in over-60s - jab uses mRNA technology like Covid
The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...
The Pharma Letter7h
BRIEF—Uncertainty over $590 million Moderna bird flu contract
US health officials are reportedly reexamining a $590 million agreement awarded to Moderna (Nasdaq: MRNA) for the development ...
UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
BioSpace12hOpinion
Opinion: How mRNA Can Help Bridge the Innovation Gap in Rare Disease
As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...
HHS weighs rescinding Moderna bird flu vaccine contract
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
Trump administration cancels meeting of FDA vaccine advisers, risking flu-shot delay
The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...